Back
Eversource Energy 10K Form
Sell
40
ES
Eversource Energy
Last Price:
$67.07
Seasonality Move:
1.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-07 | 10Q | ES/Eversource Energy Quarterly |
| 2023-08-04 | 10Q | ES/Eversource Energy Quarterly |
| 2023-05-05 | 10Q | ES/Eversource Energy Quarterly |
| 2022-11-04 | 10Q | ES/Eversource Energy Quarterly |
| 2022-08-04 | 10Q | ES/Eversource Energy Quarterly |
| 2022-05-06 | 10Q | ES/Eversource Energy Quarterly |
Receive ES News And Ratings
See the #1 stock for the next 7 days that we like better than ES
ES Financial Statistics
Sales & Book Value
| Annual Sales: | $11.9B |
|---|---|
| Cash Flow: | $-26.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $42.73 |
| Price / Book: | 1.54 |
Profitability
| EPS (TTM): | 3.63910 |
|---|---|
| Net Income (TTM): | $1.4B |
| Gross Margin: | $3.7B |
| Return on Equity: | 8.67% |
| Return on Assets: | 2.24% |
Eversource Energy Earnings Forecast
Key Eversource Energy Financial Ratios
-
The Gross Profit Margin over the past 45 years for ES is 31.12%.
-
The Selling, General & Administrative Expenses for ES have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 6.20% of Revenue.
-
The Interest Expense is 135.67% of Operating Income.
-
The Net Earning history of ES is 6.88% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 20 years.
Eversource Energy Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Electric Utilities |
| Sector: | Utilities |
| Current Symbol: | ES |
| CUSIP: | 30040W |
| Website: | eversource.com |
Debt
| Debt-to-Equity Ratio: | 1.86 |
|---|---|
| Current Ratio: | 0.71 |
| Quick Ratio: | 0.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 29.06 |
|---|---|
| Forward P/E Ratio: | 13.22 |
ES Technical Analysis vs Fundamental Analysis
Sell
40
Eversource Energy (ES)
is a Sell
Is Eversource Energy a Buy or a Sell?
-
Eversource Energy stock is rated a SellThe current Eversource Energy [ES] share price is $67.06. The Score for ES is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.